GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Verano Holdings Corp (OTCPK:VRNOF) » Definitions » EV-to-EBITDA

Verano Holdings (Verano Holdings) EV-to-EBITDA

: 9.22 (As of Today)
View and export this data going back to 2021. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Verano Holdings's enterprise value is $2,206.7 Mil. Verano Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $239.2 Mil. Therefore, Verano Holdings's EV-to-EBITDA for today is 9.22.

The historical rank and industry rank for Verano Holdings's EV-to-EBITDA or its related term are showing as below:

VRNOF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.6   Med: 27.28   Max: 206.46
Current: 9.08

During the past 5 years, the highest EV-to-EBITDA of Verano Holdings was 206.46. The lowest was 5.60. And the median was 27.28.

VRNOF's EV-to-EBITDA is ranked better than
67.56% of 706 companies
in the Drug Manufacturers industry
Industry Median: 13.805 vs VRNOF: 9.08

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-20), Verano Holdings's stock price is $4.97. Verano Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.331. Therefore, Verano Holdings's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Verano Holdings EV-to-EBITDA Historical Data

The historical data trend for Verano Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verano Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
- - 23.14 39.83 7.84

Verano Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.83 42.52 27.72 35.75 7.84

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Verano Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verano Holdings EV-to-EBITDA Distribution

For the Drug Manufacturers industry and Healthcare sector, Verano Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Verano Holdings's EV-to-EBITDA falls into.



Verano Holdings EV-to-EBITDA Calculation

Verano Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2206.688/239.218
=9.22

Verano Holdings's current Enterprise Value is $2,206.7 Mil.
Verano Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $239.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verano Holdings  (OTCPK:VRNOF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Verano Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4.97/-0.331
=At Loss

Verano Holdings's share price for today is $4.97.
Verano Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.331.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Verano Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Verano Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Verano Holdings (Verano Holdings) Business Description

Traded in Other Exchanges
Address
415 North Dearborn Street, 4th Floor, Chicago, IL, USA, 60654
Verano Holdings Corp is a vertically integrated multi?state cannabis operator in the United States. The company derives its revenues from its wholesale business and its retail dispensary chains. The retail business includes the design, build-out and operation of branded dispensaries in both medical and adult-use markets. The company's consumer brands include Encore, Avexia, MÜV, Savvy, BITS and Verano. The company's retail dispensaries operate under brands including Zen Leaf and MÜV.